Raja (Eladnani) Prince/LinkedIn
Dec 4, 2025, 02:34
Raja Prince and Team: Protein S as a Therapeutic Target
Raja Prince, Founder and BOD of BLEEDnFIRE Therapeutics, posted on LinkedIn:
”I’m delighted to share our newly published review in Journal of Thrombosis and Haemostasis (JTH).
In this article, our team provides an updated and comprehensive overview of protein S as a therapeutic target, summarizing current knowledge, emerging therapeutic strategies, and key challenges in the field of hemostasis.
A big thank you to my two coauthors, Rim Diab and Anne Angelillo-Scherrer.”
Read the full article here.
Title: Protein S as a therapeutic target
Authors: Raja Prince Eladnani, Rim Diab, Anne Angelillo-Scherrer
Stay updated with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis